Delivery Order SPE2DB22D1202-SPE2DB24FUTQ8
- Not listed
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a subsidiary of AmerisourceBergen Corporation. The order is for the supply of 4,563,982,184 units of the pharmaceutical product Ondansetron ODT 4 mg tablets, packaged in 30s. The delivery order has a ceiling value of $5,636.04 and an ultimate completion date of March 18, 2024. No set-aside designation was used. AmerisourceBergen Drug Corporation,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,564,125,413 units of the prescription drug Ondansetron ODT 8mg Tablet. The contract, valued at $1,189.99, has an ultimate completion date of April 1, 2024. As the prime contractor, Amerisourcebergen Drug Corp will deliver these pharmaceutical products from its Corporate Office in Conshohocken, Pennsylvania to support...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,728,753 units of Ondansetron ODT 8 mg tablets. The $3,297.64 contract has a completion date of February 22, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is issued under an indefinite delivery contract (IDC) valued up...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The delivery order, with a ceiling value of $3,071.44 and a period of performance through April 4, 2024, is for the supply of 4,564,150,883 units of the pharmaceutical product ondansetron ODT 8 mg tablet. Amerisourcebergen Drug Corp is the prime contractor on this...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The delivery order is for the supply of Ondansetron ODT 4 mg tablets, a pharmaceutical product, to support military treatment programs and facilities. The contract has a ceiling value of $1,711.16 and a period of performance through April 2, 2024. AmerisourceBergen Drug Corp, as the prime contractor, will...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a leading global pharmaceutical distribution company, to provide 4,563,939,458 units of the prescription drug Ondansetron ODT 4 mg tablets. The delivery order, valued at $3,344.01, has an ultimate completion date of March 13, 2024. AmerisourceBergen Drug Corp is the prime contractor and will deliver the pharmaceutical products from its Corporate Office...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,536.12, is for the delivery of 4,568,235,550 units of Ondansetron ODT 8 mg tablets in a 30-count package. The award has an ultimate completion date of May 14, 2025. Amerisourcebergen Drug Corp is the prime contractor, and the contract is not set aside for any particular...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,189,845 units of the medication Ondansetron ODT 4 MG Tablet 30S. The fixed-price contract has a ceiling value of $21,948.55 and a period of performance through May 9, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global...
- This is a firm fixed price delivery order awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The order is for 4,563,982,749 units of Ondansetron ODT 4 mg tablets, a pharmaceutical product. The total ceiling value of the order is $19,464.79 with a performance period through March 18, 2024. Amerisourcebergen Drug Corp is the prime contractor and the parent company is Cencora, Inc. which does business...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 4,563,168,936 units of Ondansetron ODT 8 mg tablets in 30-count packages, with a potential value of $3,806.30. The completion date for this order is December 26, 2023. This delivery order is not associated with any set-aside designation. Amerisourcebergen Drug Corp,...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB24FUTQ8Delivery Order
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the provision of 4,563,956,711 units of Ondansetron ODT 8 mg Tablets in 30-count packages. The total ceiling value of the order is $3,251.93 and the period of performance runs through March 14, 2024. Amerisourcebergen Drug Corp, through its Corporate Office in Conshohocken, Pennsylvania, is the prime contractor. As a for-profit organization, Amerisourcebergen Drug Corp is a major pharmaceutical sourcing and distribution services provider to U.S. government agencies, particularly the Department of Defense. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 awarded to Amerisourcebergen Drug Corp by DLA, which serves as the primary vehicle for the company to supply pharmaceuticals and medical supplies to DLA Troop Support Medical facilities worldwide in support of military treatment programs. No set-aside designation was used for this contract award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 3/13/24 |